Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-06 · accession 0001285550-22-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-08 | 2022-07-06 | CLPT | STIGALL L. JEREMY | GM, Biologics, Drug Delivery | F - Tax | $13.87 | -1,685 | 41.5K | -4% | -$23.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-06 | F | D | 1,685 | $13.87 | 41,526 | D | — | — | (F1) Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. |